Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Scott Kopetz, Howard S. Höchster, Luis A. Díaz et al.|Journal of Clinical Oncology|2020Cited by 391
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M. Loree, Scott Kopetz, Allan Andresson Lima Pereira et al.|Clinical Cancer Research|2017Cited by 318
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid TumorsKaysia Ludford, Michael J. Overman, Won Jin Ho et al.|Journal of Clinical Oncology|2023Cited by 193
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancerAmir Mehrvarz Sarshekeh, Scott Kopetz, Shailesh Advani et al.|PLoS ONE|2017Cited by 88
Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinomaZhimin Tong, Dipen M. Maru|Oncotarget|2017Cited by 19